Literature DB >> 5348467

The role of uptake2 in the extraneuronal metabolism of catecholamines in the isolated rat heart.

S L Lightman, L L Iversen.   

Abstract

1. (+/-)-(3)H-NA and labelled metabolites of NA were estimated in rat hearts after perfusion with various concentrations of NA in the range 0.01-50.0 mug/ml. Labelled metabolites of NA accounted for only a small proportion of the total uptake of radioactivity at low perfusion concentrations, but accounted for 50% of the total uptake at 1 mug NA/ml., thereafter declining to progressively smaller proportions at higher perfusion concentrations.2. If the formation of labelled metabolites of (3)H-NA was blocked by a combination of monoamine oxidase and catechol-O-methyl transferase inhibitors, the accumulation of unchanged (3)H-NA was doubled when hearts were perfused with 1 mug NA/ml.3. In hearts perfused with 0.5 mug NA/ml., an accumulation of unchanged (3)H-NA was demonstrated in the presence of a combination of metabolic inhibitors and metaraminol. This appeared to be due to Uptake(2), since the accumulation of NA under these conditions could be prevented by a low concentration of normetanephrine.4. Phenoxybenzamine prevented extraneuronal uptake (Uptake(2)) and metabolism of (3)H-NA with an estimated ID50 of 2.5 muM. The inhibition of Uptake(2) by phenoxybenzamine (2.0 muM) was diminished at very high NA concentrations, suggesting that the drug may act competitively with NA.5. It was concluded that Uptake(2) operates at all catecholamine concentrations in the rat heart, but that in the lower range (less than 2.5 mug/ml. for NA and less than 0.75 mug/ml. for adrenaline) any catecholamine taken up by this process is rapidly metabolized. Thus the accumulation of unchanged amine is seen only at high perfusion concentrations.6. The relevance of these results to an understanding of the possible physiological and pharmacological importance of Uptake(2) is discussed.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5348467      PMCID: PMC1703732          DOI: 10.1111/j.1476-5381.1969.tb08502.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  19 in total

1.  Effect of drugs on the accumulation and metabolism of extraneuronal norepinephrine in the rat heart.

Authors:  A J Eisenfeld; L Landsberg; J Axelrod
Journal:  J Pharmacol Exp Ther       Date:  1967-12       Impact factor: 4.030

2.  Inhibition of the extraneuronal accumulation and metabolism of norepinephrine by adrenergic blocking agents.

Authors:  A J Eisenfeld; J Axelrod; L Krakoff
Journal:  J Pharmacol Exp Ther       Date:  1967-04       Impact factor: 4.030

3.  Uptake of noradrenaline by adrenergic nerves, smooth muscle and connective tissue in isolated perfused arteries and its correlation with the vasoconstrictor response.

Authors:  O V Avakian; J S Gillespie
Journal:  Br J Pharmacol Chemother       Date:  1968-01

4.  The effects of phenoxybenzamine on metabolism of 3H-noradrenaline released from the isolated nictitating membrane.

Authors:  S Z Langer
Journal:  Br J Pharmacol       Date:  1968-09       Impact factor: 8.739

5.  Neuronal and extraneuronal localization of nonadrenaline in the rat heart after perfusion at high concentration.

Authors:  B Ehinger; B Sporrong
Journal:  Experientia       Date:  1968-03-15

6.  The potentiation of the responses to noradrenaline and isoprenaline of the guinea-pig isolated tracheal chain preparation by desipramine, cocaine, phentolamine, phenoxybenzamine, guanethidine, metanephrine and cooling.

Authors:  R W Foster
Journal:  Br J Pharmacol Chemother       Date:  1967-11

7.  Monoamine oxidase inhibiting properties of SU-11,739 in the rat. Comparison with pargyline, tranylcypromine and iproniazid.

Authors:  L Maître
Journal:  J Pharmacol Exp Ther       Date:  1967-07       Impact factor: 4.030

8.  Some factors determining the response of rabbit aortic strips to dl-norepinephrine-7-H3 hydrochloride and the influence of cocaine, guanethidine and methylphenidate on these factors.

Authors:  R A Maxwell; W B Wastila; S B Eckhardt
Journal:  J Pharmacol Exp Ther       Date:  1966-02       Impact factor: 4.030

9.  The uptake of isoprenaline and noradrenaline by the perfused rat heart.

Authors:  B A Callingham; A S Burgen
Journal:  Mol Pharmacol       Date:  1966-01       Impact factor: 4.436

10.  Microdetermination of catechol-O-methyl transferase in brain.

Authors:  R E McCaman
Journal:  Life Sci       Date:  1965-12       Impact factor: 5.037

View more
  71 in total

1.  Kinetics and some characteristics of uptake of noradrenaline by the human umbilical artery.

Authors:  O D Gulati; N Sivaramakrishna
Journal:  Br J Pharmacol       Date:  1975-01       Impact factor: 8.739

2.  The effect of reserpine treatment on the extraneuronal uptake of [3H]-isoprenaline into rat atria.

Authors:  A J Morton
Journal:  Br J Pharmacol       Date:  1985-09       Impact factor: 8.739

3.  Rapid transcapillary exchange and unidirectional neuronal uptake of noradrenaline in the perfused rabbit heart.

Authors:  G E Mann; D L Yudilevich
Journal:  J Physiol       Date:  1984-03       Impact factor: 5.182

4.  Involvement of uptake1 and uptake2 in terminating the cardiovascular activity of noradrenaline in normotensive and genetically hypertensive rats.

Authors:  C Bell; R Kushinsky
Journal:  J Physiol       Date:  1978-10       Impact factor: 5.182

5.  Metabolism of isoprenaline in dog and man.

Authors:  M E Conolly; D S Davies; C T Dollery; C D Morgan; J W Paterson; M Sandler
Journal:  Br J Pharmacol       Date:  1972-11       Impact factor: 8.739

6.  Inhibition of catecholamine uptake in the isolated rat heart by haloalkylamines related to phenoxybenzamine.

Authors:  L L Iversen; P J Salt; H A Wilson
Journal:  Br J Pharmacol       Date:  1972-12       Impact factor: 8.739

7.  Factors affecting the extraneuronal inactivation of noradrenaline in cardiac and smooth muscle.

Authors:  G Burnstock; M W McCulloch; D F Story; M E Wright
Journal:  Br J Pharmacol       Date:  1972-10       Impact factor: 8.739

8.  Noradrenaline uptake by non-innervated smooth muscle.

Authors:  G Burnstock; J R McLean; M Wright
Journal:  Br J Pharmacol       Date:  1971-09       Impact factor: 8.739

9.  Changes in the incidence and duration of ventricular fibrillation in dependence on the extraneuronal accumulation of isoprenaline in the perfused rat heart.

Authors:  K Sono; K Kurahashi; M Fujiwara
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-10       Impact factor: 3.000

10.  Effects of phenoxybenzamine on the uptake and metabolism of noradrenaline in the rat heart and vas deferens.

Authors:  L L Iversen; S Z Langer
Journal:  Br J Pharmacol       Date:  1969-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.